Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2021-12-21 00:00:00 ET · period of report 2021-12-21 · accession 0001808805-21-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-21 | 2021-12-21 | NAUT | Mallick Parag | Chief Scientist, Dir, 10% | G - Gift | $0.00 | -210.0K | 20.48M | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-21 | G | D | 210,000 | $0.00 | 20,479,892 | D | — | — |